Site Under Construction

Rhinophyma on hemangioma: a diagnostic conundrum

Danica-Grace R. Tungol, MD; Miguel Remigio T. Maralit, MD; Johannes F. Dayrit, MD, FPDS, FDSP



Rhinophyma, aside from persistent centrofacial redness is a major diagnostic criteria for rosacea. Phyma may be mistaken for hypertrophy of tissue due to an underlying hemangioma.

Case report

A 35-year-old female presented with few erythematous papules on the face and nose 19 years prior to consult. Lesions evolved into multiple erythematous nodules on nose and was mistaken for tissue hypertrophy due to an adjacent congenital hemangioma. Her hemangioma was treated with pulsed dye laser 16 years prior with noted decrease in size and erythema. Recently she noticed enlargement of her nose with persistent redness. She presented with multiple firm, thick irregularly shaped erythematous nodules with prominent pilosebaceous pores and telangiectasia on the nose. Skin punch biopsy was done which revealed hypertrophy and lysis of sebaceous lobules with a moderately dense inflammatory infiltrate of lymphocytes. Histopathological diagnosis was rhinophyma. Patient was treated with low dose isotretinoin (0.20 mkd) with marked flattening of lesions in just one month.


Distinguishing phyma from tissue hypertrophy caused by hemangioma poses as a diagnostic challenge. Careful dermatological examination and histopathological findings will aid in correct diagnosis. Low dose oral isotretinoin is an effective treatment for rhinophyma.


  1. Gallo R, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol, 2017 (
  2. Steinhoff M and Buddenkotte J. Rosacea. In: Kang S et. al. ed. Fitzpatrick’s Dermatology 9th edition New York, NY: McGraw-Hill Companies, Inc; 2019 79: 1419-1447.
  3. George A, Mani V, Noufal A Update on the classification of hemangioma. J Oral Maxillofac Pathol. 2014;18:S117–20. doi: 10.4103/0973-029X.141321.
  4. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749–758.
  5. Aloi F, Tomasini C, Soro E, Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol. 2000;42: 468-472.
  6. Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761–770. quiz 771–772.

REquesting Permission

Rhinophyma on hemangioma: a diagnostic conundrum